Cargando…
An evidence-based debate on epigenetics and immunosenescence in COVID-19
Immunosenescence contributes to the decline of immune function leading to a reduced ability to respond to severe coronavirus disease 2019 (COVID-19) in elderly patients. Clinical course of COVID-19 is widely heterogeneous and guided by the possible interplay between genetic background and epigenetic...
Autores principales: | Napoli, Claudio, Coscioni, Enrico, Trama, Ugo, Strozziero, Maria Grazia, Benincasa, Giuditta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539895/ https://www.ncbi.nlm.nih.gov/pubmed/37781451 http://dx.doi.org/10.1016/j.crimmu.2023.100069 |
Ejemplares similares
-
Immunosenescence exacerbates the COVID-19
por: Napoli, Claudio, et al.
Publicado: (2020) -
Epigenetic Therapies for Heart Failure: Current Insights and Future Potential
por: Napoli, Claudio, et al.
Publicado: (2021) -
Differential epigenetic factors in the prediction of cardiovascular risk in diabetic patients
por: Napoli, Claudio, et al.
Publicado: (2020) -
Clinical Role of Epigenetics and Network Analysis in Eye Diseases: A Translational Science Review
por: Lanza, Michele, et al.
Publicado: (2019) -
Risk of SARS-CoV-2 Infection Breakthrough among the Non-Vaccinated and Vaccinated Population in Italy: A Real-World Evidence Study Based on Big Data
por: Perrella, Alessandro, et al.
Publicado: (2022)